Jermaine D Jones1, Aimee Campbell2, Verena E Metz2, Sandra D Comer2. 1. Division on Substance Use Disorders, New York State Psychiatric Institute, College of Physicians and Surgeons, Columbia University, 1051 Riverside Drive, New York, NY 10032, USA; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, 1051 Riverside Drive, New York, NY 10032, USA. Electronic address: jonesje@nyspi.columbia.edu. 2. Division on Substance Use Disorders, New York State Psychiatric Institute, College of Physicians and Surgeons, Columbia University, 1051 Riverside Drive, New York, NY 10032, USA; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, 1051 Riverside Drive, New York, NY 10032, USA.
Abstract
INTRODUCTION: Some fear that distribution of naloxone to persons at risk of experiencing an opioid overdose may reduce the perceived negative consequences of drug use, leading to riskier patterns of use. This study assessed whether participation in naloxone/overdose training altered drug use frequency, quantity or severity among heroin users in and out of treatment. METHODS: Clinical interviews were performed assessing patterns of heroin and other drug use prior to, and at multiple timepoints after overdose education and naloxone training. This study compared baseline drug use to that at 1 and 3months post training. RESULTS: Both current heroin users (n=61) and former users in agonist maintenance (n=69) typically showed decreases in heroin and polydrug use at both 1 and 3months after training. The Addiction Severity Index drug composite score also decreased at follow up. CONCLUSIONS: This analysis found no evidence of compensatory drug use following naloxone/overdose training among two groups of heroin users. These findings support the acceptance and expansion of naloxone distribution to at-risk populations and may assist in allaying concerns about the potential for unintended negative consequences on drug use.
INTRODUCTION: Some fear that distribution of naloxone to persons at risk of experiencing an opioid overdose may reduce the perceived negative consequences of drug use, leading to riskier patterns of use. This study assessed whether participation in naloxone/overdose training altered drug use frequency, quantity or severity among heroin users in and out of treatment. METHODS: Clinical interviews were performed assessing patterns of heroin and other drug use prior to, and at multiple timepoints after overdose education and naloxone training. This study compared baseline drug use to that at 1 and 3months post training. RESULTS: Both current heroin users (n=61) and former users in agonist maintenance (n=69) typically showed decreases in heroin and polydrug use at both 1 and 3months after training. The Addiction Severity Index drug composite score also decreased at follow up. CONCLUSIONS: This analysis found no evidence of compensatory drug use following naloxone/overdose training among two groups of heroin users. These findings support the acceptance and expansion of naloxone distribution to at-risk populations and may assist in allaying concerns about the potential for unintended negative consequences on drug use.
Authors: Jonathan P Feelemyer; Don C Des Jarlais; Kamyar Arasteh; Benjamin W Phillips; Holly Hagan Journal: Drug Alcohol Depend Date: 2013-10-24 Impact factor: 4.492
Authors: Jermaine D Jones; Jared J Atchison; Gabriela Madera; Verena E Metz; Sandra D Comer Journal: Drug Alcohol Depend Date: 2015-05-27 Impact factor: 4.492
Authors: Karen H Seal; Moher Downing; Alex H Kral; Shannon Singleton-Banks; Jon-Paul Hammond; Jennifer Lorvick; Dan Ciccarone; Brian R Edlin Journal: J Urban Health Date: 2003-06 Impact factor: 3.671
Authors: Michael A Irvine; Margot Kuo; Jane A Buxton; Robert Balshaw; Michael Otterstatter; Laura Macdougall; M-J Milloy; Aamir Bharmal; Bonnie Henry; Mark Tyndall; Daniel Coombs; Mark Gilbert Journal: Addiction Date: 2019-06-28 Impact factor: 6.526
Authors: Sean T Allen; Rebecca Hamilton White; Allison O'Rourke; Suzanne M Grieb; Michael E Kilkenny; Susan G Sherman Journal: Drug Alcohol Depend Date: 2019-09-21 Impact factor: 4.492
Authors: Stephen Parkin; Joanne Neale; Caral Brown; Aimee N C Campbell; Felipe Castillo; Jermaine D Jones; John Strang; Sandra D Comer Journal: Int J Drug Policy Date: 2020-04-15
Authors: Jermaine D Jones; Aimee N Campbell; Laura Brandt; Verena E Metz; Suky Martinez; Melanie Wall; Thomas Corbeil; Howard Andrews; Felipe Castillo; Joanne Neale; John Strang; Stephen Ross; Sandra D Comer Journal: Drug Alcohol Depend Date: 2022-05-23 Impact factor: 4.852